v3.26.1
Nature of the Business (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
May 12, 2026
Feb. 05, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 22, 2025
Subsidiary, Sale of Stock [Line Items]            
Common stock, par value (in usd per share)   $ 0.00001 $ 0.00001   $ 0.00001 $ 0.00001
Net losses     $ 27,232 $ 12,400    
Negative cash flows from operations     21,168 $ 13,317    
Accumulated deficit     150,653   $ 123,421  
Subsequent event            
Subsidiary, Sale of Stock [Line Items]            
Common stock, par value (in usd per share) $ 0.00001          
Warrants, exercise price (in usd per share) $ 0.00001          
Warrants, exercise restriction, maximum percentage of outstanding common stock if exercised 9.99%          
Warrants, exercise restriction, maximum percentage of outstanding common stock if exercised after 61 day notice period 19.99%          
Gross proceeds from offerings $ 472,000          
IPO            
Subsidiary, Sale of Stock [Line Items]            
Gross proceeds from sale of stock   $ 294,800        
Net proceeds from sale of stock   $ 269,100        
Follow-On Public Offering | Subsequent event            
Subsidiary, Sale of Stock [Line Items]            
Gross proceeds from sale of stock $ 442,000          
Private Placement | Subsequent event            
Subsidiary, Sale of Stock [Line Items]            
Common stock issuable for warrants (in shares) 300,000          
Warrants, purchase price (in usd per share) $ 99.99999          
Proceeds from sale of warrants $ 30,000          
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Stock issued for conversion (in shares)   19,250,410        
Common Stock | IPO            
Subsidiary, Sale of Stock [Line Items]            
Sale of stock (in shares)   17,339,294        
Sale of stock, price (in usd per share)   $ 17.00        
Gross proceeds from sale of stock     $ 294,800      
Common Stock | Underwriters' over-allotment option            
Subsidiary, Sale of Stock [Line Items]            
Sale of stock (in shares)   2,261,647        
Common Stock | Underwriters' over-allotment option | Subsequent event            
Subsidiary, Sale of Stock [Line Items]            
Sale of stock (in shares) 576,568          
Common Stock | Follow-On Public Offering | Subsequent event            
Subsidiary, Sale of Stock [Line Items]            
Sale of stock (in shares) 4,420,358          
Sale of stock, price (in usd per share) $ 100.00